These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4460724)

  • 1. Enzymatic 5-hydroxylation of 3,4-dimethoxybeta-phenethylamine.
    Benington F; Morin RD
    Ala J Med Sci; 1974 Oct; 11(4):354-5. PubMed ID: 4460724
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans.
    Charalampous KD
    Behav Neuropsychiatry; 1971; 2(11):26-9 passim. PubMed ID: 5566331
    [No Abstract]   [Full Text] [Related]  

  • 4. The roles of 3,4,5-trihydroxy-beta-phenethylamine and 3,4-dimethoxy-beta-phenethylamine in the biosynthesis of Mescaline.
    Paul AG; Rosenberg H; Khanna KL
    Lloydia; 1969 Mar; 32(1):36-9. PubMed ID: 5788765
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans.
    Friedhoff AJ; Hollister LE
    Biochem Pharmacol; 1966 Mar; 15(3):269-73. PubMed ID: 5911541
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences between amine oxidases deaminating mescaline and the structurally related 3,4-dimethoxyphenylethyl amine.
    Huszti Z; Borsy J
    Biochem Pharmacol; 1966 Apr; 15(4):475-80. PubMed ID: 5954979
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and distribution kinetics in animals of [alpha-11C] 3,4-dimethoxyphenethylamine.
    Mestelan G; Crouzel C; Comar D
    Int J Nucl Med Biol; 1977 Dec; 4(3-4):185-93. PubMed ID: 608804
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative measurement of demethylation of 14C-methoxyl labeled DMPEA and TMA-2 in rats.
    Sargent T; Shulgin AT; Kusubov N
    Psychopharmacol Commun; 1976; 2(3):199-206. PubMed ID: 996275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of mescaline and 3,4-dimethoxy-phenylethylamine in isolated brain mitochondria and brain homogenate.
    Shah NS; Himwich HE
    Brain Res; 1971 Nov; 34(1):163-70. PubMed ID: 5124914
    [No Abstract]   [Full Text] [Related]  

  • 10. The N-hydroxylation of phentermine (2-methyl-1-phenylisopropylamine) by rabbit liver microsomes.
    Cho AK; Lindeke B; Hodshon BJ
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):519-28. PubMed ID: 4638590
    [No Abstract]   [Full Text] [Related]  

  • 11. THE EFFECTS OF RING-METHYOXYL GROUPS ON BIOLOGICAL DEAMINATION OF PHENETHYLAMINES.
    CLARK LC; BENINGTON F; MORIN RD
    J Med Chem; 1965 May; 8():353-5. PubMed ID: 14323146
    [No Abstract]   [Full Text] [Related]  

  • 12. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. URINARY EXCRETION OF A 3-4, DIMETHOXYPHENYLETHYLAMINE-LIKE SUBSTANCE IN PARKINSON'S DISEASE.
    BARBEAU A; DEGROOT JA; JOLY JG; RAYMOND-TREMBLAY D; DONALDSON J
    Rev Can Biol; 1963; 22():469-72. PubMed ID: 14142201
    [No Abstract]   [Full Text] [Related]  

  • 14. Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: sites of electroencephalographic arousal.
    Takeo Y; Himwich HE
    Science; 1965 Dec; 150(3701):1309-10. PubMed ID: 5856999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enzymatic formation of 3,4-di-O-methylated dopamine metabolites by mammalian tissues.
    Friedhoff AJ; Schweitzer JW; Miller J
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):293-311. PubMed ID: 4679853
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of a low dosage of mescaline and 3,4-dimethoxyphenylethylamine under two levels of aversive stimulation.
    Levis DJ; Caldwell DF
    Biol Psychiatry; 1971; 3(3):251-7. PubMed ID: 5163810
    [No Abstract]   [Full Text] [Related]  

  • 17. Physiological disposition of beta-phenylethylamine, 2,4,5-trimethoxyphenylethylamine, 2,3,4,5,6-pentamethoxyphenylethylamine and beta-hydroxymescaline in rat brain, liver and plasma.
    Cohen I; Fischer JF; Vogel WH
    Psychopharmacologia; 1974 Mar; 36(1):77-84. PubMed ID: 4838506
    [No Abstract]   [Full Text] [Related]  

  • 18. N-oxygenation of phenethylamine to the trans-oxime by adult human liver flavin-containing monooxygenase and retroreduction of phenethylamine hydroxylamine by human liver microsomes.
    Lin J; Cashman JR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1269-79. PubMed ID: 9316835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3,4-dimethoxyphenylethylamine in man.
    Hollister LE; Friedhoff AJ
    Nature; 1966 Jun; 210(5043):1377-8. PubMed ID: 5963772
    [No Abstract]   [Full Text] [Related]  

  • 20. Microsomal N-hydroxylation of phenylalkylamines. Identification of N-hydroxylated phenylalkylamines as their trimethylsilyl derivatives by GC-Ms.
    Lindeke B; Cho AK; Thomas TL; Michelson L
    Acta Pharm Suec; 1973 Dec; 10(6):493-506. PubMed ID: 4773116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.